Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-000098-35Phase 4Active
Phase 4 trial of propofol and sevoflurane in temporomandibular disorder (TMD) and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Hospital Universitario La Paz. Primary endpoints: Presence and intensity of postoperative nausea and vomiting at 2 hours, Presence and intensity of postoperative nausea and vomiting at 6 hours and 1 more. Started Jul 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-000098-35.